Press / Medias

Cornell patent deal helps LNC ramp-up microbiome therapeutics strategy

Dec 17, 2018

A new patent licencing deal between Cornell and LNC Therapeutics will help the French biotech become the ‘must have’ partner for research and product development relating to the Christensenella strain, says the company’s CEO.

Clic here to read the full article

 

 

In the same category

Press / Medias

EMA & FDA Apply a Similar Mindset When Providing Scientific Advice For Live Biotherapeutic...

Sep 13, 2021

more +
Press / Medias

Bordeaux : un traitement prometteur contre l’obésité développé à base d’une...

Jun 16, 2021

more +
Press / Medias

Le pari gagnant du microbiome

May 24, 2021

more +

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions